Mega Genomics Limited (6667.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap1.98B
Enterprise Value1.51B
P/E Ratio43.35
PEG Ratio0.43
Price/Sales Ratio9
Price/Book Ratio1.99
Enterprise/Revenue5.89
Enterprise/EBITDA17.01

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterJune 30, 2024

Profitability

Profit Margin0.2
Operating Margin0.12
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.05

Income Statement

Revenue151.3M
Revenue/Share0.71
Gross Profit88.3M
EBITDA52.42M
Net Income30.04M
Diluted EPS0.14

Balance Sheet

Total Cash508.93M
Total Cash/Share2.45
Total Debt41.42M
Total Debt/Equity0.08
Current Ratio5.84
Book Value Per Share3.04

Price History

52-Week Change-2.5
52-Week High7.53
52-Week Low5
Moving Average 50 Days7.06
Moving Average 200 Days7.16

Statistics

Average Volume2,349
Shares Outstanding224.3M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.15
Trailing Annual Dividend Yield2.42
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD